Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Plasma Aβ42/Aβ40 is sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the Alzheimer's disease spectrum 2024-12-23
  2. The clinical use of blood-test factors for Alzheimer's disease: improving the prediction of cerebral amyloid deposition by the QPLEXTM Alz plus assay kit 2021-06-09
  3. Visual contrast sensitivity is associated with the presence of cerebral amyloid and tau deposition 2020-02-26

Studies

6 studies carry this tag.

Date range

2013 to 2024

Top journals

  • Acta neuropathologica 1
  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • Brain communications 1
  • Experimental & molecular medicine 1
  • Neurobiology of aging 1

6 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Plasma Aβ42/Aβ40 is sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the Alzheimer's disease spectrum

    ✓ Peer-reviewed alzhub usefulness score 59 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2024-12-23 Biomarkers

    Lumipulse plasma Aβ 42 /Aβ 40 is a scalable assay for detection of cerebral Aβ and prediction of risk for cognitive decline across the AD continuum.

  2. The clinical use of blood-test factors for Alzheimer's disease: improving the prediction of cerebral amyloid deposition by the QPLEXTM Alz plus assay kit

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Experimental & molecular medicine 2021-06-09 Biomarkers

    Alzheimer's disease (AD) is the leading cause of dementia, and many studies have focused on finding effective blood biomarkers for the accurate diagnosis of this disease.

  3. Visual contrast sensitivity is associated with the presence of cerebral amyloid and tau deposition

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Brain communications 2020-02-26 Brain scans and imaging

    Visual deficits are common in neurodegenerative diseases including Alzheimer's disease.

  4. Blood acetylcholinesterase level is a potential biomarker for the early detection of cerebral amyloid deposition in cognitively normal individuals

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Neurobiology of aging 2018-09-08 Biomarkers

    Cerebral β-amyloid (cAβ) deposition and cholinergic dysfunction have been considered as major pathological and functional hallmarks of Alzheimer's disease (AD).

  5. A high-glycemic diet is associated with cerebral amyloid burden in cognitively normal older adults

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. The American journal of clinical nutrition 2017-10-25 Brain scans and imaging

    Amyloid was elevated in 26% ( n = 33) of participants.

  6. Cerebral amyloid PET imaging in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Acta neuropathologica 2013-10-08 Brain scans and imaging

    The devastating effects of the still incurable Alzheimer's disease (AD) project an ever increasing shadow of burden on the health care system and society in general.

All topic tags with their study counts